Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 14.30
-0.20 (-1.38%)
At close: Nov 28, 2025
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 9.61 billion as of November 28, 2025. Its market cap has increased by 248.69% in one year.
Market Cap
9.61B
Enterprise Value
7.14B
Revenue
678.11M
Ranking
n/a
PE Ratio
58.60
Stock Price
14.30
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 9.61B, an increase of 10.38%. That is a compound annual growth rate of 2.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 9.61B | 234.29% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 293.44B |
| Hansoh Pharmaceutical Group Company | 243.49B |
| JD Health International | 195.61B |
| Innovent Biologics | 161.27B |
| WuXi Biologics | 128.31B |
| Sino Biopharmaceutical | 126.03B |
| Akeso | 113.21B |
| Sichuan Kelun-Biotech Biopharmaceutical | 106.43B |